XML 101 R92.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 13 - Stockholders' Equity - Stock Option Activity (Details) - USD ($)
9 Months Ended 12 Months Ended
Jun. 30, 2016
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2013
Outstanding (in shares) 1,370,000 1,224,000 1,030,000  
Outstanding, Weighted Average Exercise Price Per Share (in dollars per share) $ 6.34 $ 6.40 $ 6.60  
Outstanding, Weighted Average Grant-Date Fair Value Per Share (in dollars per share) $ 1.14 $ 1 $ 0.80  
Outstanding, Weighted Average Remaining Contractual Term 3 years 208 days 4 years 43 days 4 years 251 days 6 years 182 days
Granted (in shares)   180,000 194,000  
Granted, Weighted Average Exercise Price Per Share (in dollars per share)   $ 5.50 $ 5.30  
Granted, Weighted Average Grant-Date Fair Value Per Share (in dollars per share)   $ 2.14 $ 2.20  
Granted, Weighted Average Remaining Contractual Term   7 years 266 days 8 years 160 days  
Outstanding (in shares) 1,224,500 1,370,000 1,224,000 1,030,000
Outstanding, Weighted Average Exercise Price Per Share (in dollars per share) $ 6.51 $ 6.34 $ 6.40 $ 6.60
Outstanding, Weighted Average Grant-Date Fair Value Per Share (in dollars per share) $ 1.23 $ 1.14 $ 1 $ 0.80
Outstanding, Aggregate Intrinsic Value     $ 104,000  
Forfeited or expired (in shares) (45,500) (34,000)    
Forfeited or expired, Weighted Average Exercise Price Per Share (in dollars per share) $ 6.32 $ 5    
Forfeited or expired, Weighted Average Grant-Date Fair Value Per Share (in dollars per share) $ 1.44 $ 2.30    
Forfeited or expired, Weighted Average Remaining Contractual Term   8 years 14 days    
Vested and exercisable (in shares)   1,238,000    
Vested and exercisable, Weighted Average Exercise Price Per Share (in dollars per share)   $ 6.42    
Vested and exercisable, Weighted Average Grant-Date Fair Value Per Share (in dollars per share)   $ 1.02    
Vested and exercisable, Weighted Average Remaining Contractual Term   3 years 277 days